Your browser doesn't support javascript.
loading
Molecular and Genomic Determinants of Response to Immune Checkpoint Inhibition in Cancer.
Jenkins, Russell W; Thummalapalli, Rohit; Carter, Jacob; Cañadas, Israel; Barbie, David A.
Affiliation
  • Jenkins RW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; email: dbarbie@partners.org.
  • Thummalapalli R; Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts 02114, USA.
  • Carter J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; email: dbarbie@partners.org.
  • Cañadas I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; email: dbarbie@partners.org.
  • Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; email: dbarbie@partners.org.
Annu Rev Med ; 69: 333-347, 2018 01 29.
Article in En | MEDLINE | ID: mdl-29099676
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / CTLA-4 Antigen / Programmed Cell Death 1 Receptor / Antineoplastic Agents, Immunological / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Annu Rev Med Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / CTLA-4 Antigen / Programmed Cell Death 1 Receptor / Antineoplastic Agents, Immunological / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Annu Rev Med Year: 2018 Type: Article